Cargando…

Causes of Pulmonary Fibrosis in the Elderly

Idiopathic pulmonary fibrosis (IPF) is the most common and most lethal type of idiopathic interstitial pneumonia. It is a chronic, aging-associated lung disease characterized by fibrotic foci and inflammatory infiltrates, with no cure and very limited therapeutic options. Although its etiology is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Ramírez, Cecilia, Suarez Valdivia, Lionel, Rodríguez Portal, Jose Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164854/ https://www.ncbi.nlm.nih.gov/pubmed/30042329 http://dx.doi.org/10.3390/medsci6030058

Ejemplares similares

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Environmental Causes of Idiopathic Pulmonary Fibrosis
por: Gandhi, Sheiphali, et al.
Publicado: (2023)

Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry
por: Fernández-Fabrellas, Estrella, et al.
Publicado: (2019)

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target
por: Galán-Cobo, Ana, et al.
Publicado: (2018)

Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial
por: Badenes-Bonet, Diana, et al.
Publicado: (2021)

Mounier-Kuhn Syndrome in an Elderly Female with Pulmonary Fibrosis
por: Boglou, Panagiotis, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Pulmonary Fibrosis in Children
por: Nathan, Nadia, et al.
Publicado: (2019)

Irreversibility of Pulmonary Fibrosis
por: Yu, Qing Yang, et al.
Publicado: (2022)

Pulmonary fibrosis in sarcoidosis
por: Asif, Huda, et al.
Publicado: (2023)

Afectación pulmonar tras la infección aguda por SARS-CoV-2
por: López Bauzá, Ángela, et al.
Publicado: (2022)

Effects of Exercise Training on Cardiopulmonary Function and Quality of Life in Elderly Patients with Pulmonary Fibrosis: A Meta-Analysis
por: Li, Xiaohan, et al.
Publicado: (2021)

Nodular Pulmonary Amyloidosis: A Rare Clinical Entity()
por: Cuenca Peris, Selene, et al.
Publicado: (2023)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
por: Cîrjaliu, Roxana-Elena, et al.
Publicado: (2023)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential
por: Ramírez-Hernández, Alma Aurora, et al.
Publicado: (2022)

Integrating mechanisms of pulmonary fibrosis
por: Wynn, Thomas A.
Publicado: (2011)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
por: Tirelli, Claudio, et al.
Publicado: (2022)

Non-cystic fibrosis bronchiectasis in the elderly: current perspectives
por: Quinn, Tom M, et al.
Publicado: (2018)

Update on diagnosis and treatment of idiopathic pulmonary fibrosis
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis: pathogenesis and management
por: Sgalla, Giacomo, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
por: Cano-Jiménez, Esteban, et al.
Publicado: (2018)

Cell Therapy in Idiopathic Pulmonary Fibrosis†
por: Serrano-Mollar, Anna
Publicado: (2018)

Lung Transplantation in Idiopathic Pulmonary Fibrosis
por: Laporta Hernandez, Rosalía, et al.
Publicado: (2018)

Physiology of the lung in idiopathic pulmonary fibrosis
por: Plantier, Laurent, et al.
Publicado: (2018)

Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma
por: Mazzotta, Marco, et al.
Publicado: (2016)

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis
por: Sakayori, Masashi, et al.
Publicado: (2019)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)

Clinical significance of pectoralis muscle strength in elderly patients with idiopathic pulmonary fibrosis
por: Durdu, Habibe, et al.
Publicado: (2022)

Novel therapeutic approaches for pulmonary fibrosis
por: Datta, Arnab, et al.
Publicado: (2011)

Molecular and cellular mechanisms of pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2012)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Recent Advances in Idiopathic Pulmonary Fibrosis
por: Park, Sanghoon, et al.
Publicado: (2013)

Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015)

Idiopathic Pulmonary Fibrosis: Treatment and Prognosis
por: Fujimoto, Hajime, et al.
Publicado: (2016)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kishaba, Tomoo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fi5c19bpeku9ebb848anjnftoa